Arcadia Biosciences Welcomes Eric J. Rey and Gregory D. Waller to Its Board Of Directors

Arcadia Biosciences, Inc., an agricultural technology company that creates value for farmers while benefitting the environment and enhancing human health, announced today that Eric J. Rey and Gregory D. Waller have joined its board of directors. The two were elected at the company’s annual stockholders meeting to replace directors Vic Knauf, Ph.D., and Rajiv Shah, M.D.

Additionally, the board of directors formally elected George F.J. Gosbee as its chair. Gosbee has served as interim chair of the board since November 2016.

“We are fortunate to have Eric and Greg join the board, two directors with the experience, and industry insight needed to help Arcadia grow the business,” said George Gosbee, chair of the board of directors. “I would also like to thank Vic Knauf and Raj Shah for their service and contributions to the board.”

Rey is one of the founders of Arcadia Biosciences and served as president and CEO, as well as a director, until 2016. Prior to founding Arcadia, Rey was a partner with Rockridge Group, a management consulting firm for early-stage companies developing genomic, biopharmaceutical, nutraceutical, crop protection, animal nutrition and health, alternative crop and industrial products. He previously served as vice president of operations with Calgene, Inc., including two years with Monsanto Company following its acquisition of Calgene. Rey holds a B.S. in plant science from the University of California, Davis. He currently serves as a director for Phytelligence, Inc. and Texas Crop Science, LLC.

Waller is the former chief financial officer (CFO) of Ulthera Corporation, a privately-held company providing ultrasound technology for aesthetic and medical applications, which was acquired by Merz North America in 2014. Previously, Waller was CFO of Universal Building Products and Sybron Dental Specialties, Inc., and vice president and treasurer of Kerr, Ormco Corporation, and Metrex. Waller has an MBA with a concentration in accounting from California State University, Fullerton. He has extensive experience serving on the boards of public companies and currently serves as a director for Sunshine Heart and Endologix Corporation.